KIF11 DEPENDENCY ON P53 MUTATIONAL STATUS IN MEDULLOBLASTOMA

被引：1
|
作者：
Huang, Shiying [1 ,2 ]
Karthik, Sekar [1 ]
Lin, Qi [3 ]
Du, YuChen [3 ]
Lau, Ching C. [4 ]
Adekunle, Adesina [5 ]
Su, Jack M. F. [4 ,6 ]
Major, Angela [7 ]
Elghetany, M. Tarek [6 ,7 ]
Hui, Kam-Man [1 ]
Li, Xiaonan [3 ,8 ]
Teo, Wan-Yee [1 ,2 ,9 ,10 ,11 ]
机构：
[1] Natl Canc Ctr Singapore, Humphrey Oei Inst Canc Res, Singapore, Singapore
[2] SingHlth Duke NUS Acad Med Ctr, Pediat Brain Tumor Res Off, Singapore, Singapore
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA
[4] Texas Childrens Canc Ctr, Div Hematol Oncol, Dept Pediat, Houston, TX USA
[5] Texas Childrens Hosp, Dept Mol Pathol, Houston, TX 77030 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] Dept Pathol, Houston, TX USA
[8] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[9] KK Hosp Singapore, Singapore, Singapore
[10] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore
[11] Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
10.1093/neuonc/noab090.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EMBR-23
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [1] Heterogeneity of p53 mutational status in intramucosal carcinoma of the colorectum
    Yamada, S
    Ajioka, Y
    Watanabe, H
    Hashidate, H
    Takaku, H
    Kazama, S
    Yokoyama, J
    Nishikura, K
    Fujiwara, T
    Asakura, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (02): : 161 - 166
  • [2] The mutation status of PAX3 and p53 genes in medulloblastoma
    Wang, WG
    Kumar, P
    Wang, WZ
    Whalley, J
    Schwarz, M
    Malone, G
    Haworth, A
    Kumar, S
    ANTICANCER RESEARCH, 1998, 18 (2A) : 849 - 853
  • [3] Heterogeneity of p53 mutational status in esophageal squamous cell carcinoma
    Kuwabara, S
    Ajioka, Y
    Watanabe, H
    Hitomi, J
    Nishikura, K
    Hatakeyama, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (04): : 405 - 410
  • [4] Proteomic signatures associated with p53 mutational status in lung adenocarcinoma
    Taguchi, Ayumu
    Delgado, Oliver
    Celiktas, Muege
    Katayama, Hiroyuki
    Wang, Hong
    Gazdar, Adi F.
    Hanash, Samir M.
    PROTEOMICS, 2014, 14 (23-24) : 2750 - 2759
  • [5] P53 REGULATES IMMUNOGENICITY OF MEDULLOBLASTOMA
    Garancher, Alexandra
    Wechsler-Reya, Robert J.
    NEURO-ONCOLOGY, 2017, 19 : 29 - 29
  • [6] Kif11 Inhibition Preferentially Kills TP53-mutant Breast Cancer Cells
    Lanier, Amanda
    Tahaney, William
    Qian, Jing
    Moyer, Cassandra
    Ma, Yanxia
    Arun, Banu
    Mazumdar, Abhijit
    Brown, Powel
    CANCER RESEARCH, 2024, 84 (09)
  • [7] p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status
    Tolbert, DM
    Noffsinger, AE
    Miller, MA
    DeVoe, GW
    Stemmermann, GN
    Macdonald, JS
    Fenoglio-Preiser, CM
    MODERN PATHOLOGY, 1999, 12 (01) : 54 - 60
  • [8] P53 protein, expression levels are prognostic in AML and predict for mutational status
    Kornblau, Steven M.
    Barnett, Joseph
    Qiu, YiHua
    Chen, Wenjing
    Faderl, Stefan
    Coombes, Kevin R.
    Andreeff, Michael
    BLOOD, 2007, 110 (11) : 708A - 708A
  • [9] Folate intake and risk of colon cancer in relation to p53 mutational status
    Schernhammer, E.
    Ogino, S.
    Fuchs, C.
    EJC SUPPLEMENTS, 2008, 6 (03): : 49 - 49
  • [10] Correlation between p53 immunohistochemistry and mutational status in human melanoma tumors
    Palmer, M.
    Horrigan, K.
    Wang, Y.
    Yu, Y.
    Sirko-Osadsa, D. A.
    Lee, B. H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S32 - S33
12345